Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spyglass-guided Lithotripsy Vs ESWL for Pancreatic Duct Stones

NCT05475782 is registered in ClinicalTrials.gov with First People's Hospital of Hangzhou as lead sponsor.

NCT NCT05475782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05475782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spyglass-guided Lithotripsy Vs ESWL for Pancreatic Duct Stones
Lead sponsor
First People's Hospital of Hangzhou
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2021
Completion date
December 1, 2025
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic duct stone